EPIZON PHARMA

Welcome to the Brand page for “EPIZON PHARMA”, which is offered here for The mark consists of the word epizon featuring a benzene ring as the o followed by the word pharma.;pharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart disease, osteoporosis, bone disease, renal disease, kidney disease, auto immune disease, arteriosclerosis, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reaction, anaphylaxis or asthma;color is not claimed as a feature of the mark.;pharma;development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reactions, anaphylaxis or asthma;.

Its status is currently believed to be active. Its class is unavailable. “EPIZON PHARMA” is believed to be currently owned by “Epizon Pharma, Inc.”

Owner:
EPIZON PHARMA, INC.
Owner Details
Description:
The mark consists of the word EPIZON featuring a benzene ring as the O followed by the word PHARMA.;pharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart disease, osteoporosis, bone disease, renal disease, kidney disease, auto immune disease, arteriosclerosis, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reaction, anaphylaxis or asthma;Color is not claimed as a feature of the mark.;PHARMA;development of pharmaceutical preparations and medicines; pharmaceutical products development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research in the field of pharmaceuticals and drugs, excluding devices or drug systems for the delivery of pharmaceuticals for the treatment of allergic reactions, anaphylaxis, or asthma and pharmaceuticals for the treatment of allergic reactions, anaphylaxis or asthma;
Categories: